In the entire cohort, the endoscopic tumor length (P <0.001), bioptic tumor differentiation (P <0.001), clinical T stage (P <0.001), and preoperative CEA (P <0.001) in the RLN LNM-positive group were significantly different from those in the RLN LNM-negative group. Here, CEACAM5 is linked to neoplasm.